Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram vs citalopram in major depressive disorder
2004-000320-32Phase 4Terminated
- Sponsor
- Lundbeck
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Escitalopram 20 mg/day with Citalopram 40 mg/day (2 arms). Primary endpoint: Primary efficacy (MADRS total score at 8 weeks). Started Oct 2004; status: terminated.
02
Drugs
escitalopramcitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2004-000320-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000320-32.